BridgeMD
New treatment option for Major Depressive Disorder (MDD)
Official title Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression
ClinicalTrials.gov ID: NCT07324070
What this study is testing
- What it's testing
- The RTMSECT2 study was design to compare the application of electroconvulsive therapy augmented by transcranial magnetic stimulation. Subject will be compared both within groups and in group using psychometric scales and different deliver energy
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age equal to 18 or higher
- MADRS (Montgomery-Asberg Depression Scale) qual or higher than 20
- Major depressive disorder according to ICD 10
You likely can't join if
- Other axis 1 disorder (for example schizofrenia, addiction, etc.)
- No dementia
- ECT in the last 3 months
- TMS in the last 3 months
- Psychotic disease or symptoms
- Ppregnancy or lactation
See the full eligibility criteria
- Age equal to 18 or higher
- MADRS (Montgomery-Asberg Depression Scale) qual or higher than 20
- Major depressive disorder according to ICD 10
- Other axis 1 disorder (for example schizofrenia, addiction, etc.)
- No dementia
- ECT in the last 3 months
- TMS in the last 3 months
- Psychotic disease or symptoms
- Ppregnancy or lactation
- Any neurological disease (for example epilepsy, etc.)
- Participation in another clinical trial within the last 30 days
- somatic condition which contraindicates ECT
The study team makes the final eligibility decision.
Where it's taking place
- Prague, Czech, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Prague, Czech, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.